Growth momentum Endpoint Clinical recently expanded with the Elosity R3 release, signaling ongoing product development, potential upsell opportunities around RTSM enhancements, AI-driven trial insights, and expanded clinical supply capabilities to support larger or more complex trials.

Global footprint With headquarters in Raleigh and offices across the US, EU, and Asia, Endpoint Clinical is positioned to engage multi-region trials and cross-border programming, presenting opportunities to bundle regional RTSM services, regulatory support, and global supply management.

Leadership signals Recent executive hires in US West, EMEA, and APAC dedicated to business development and quality leadership indicate a focus on revenue growth, strategic partnerships, and scalable operations—opening doors for channel partnerships and co-sell arrangements.

Industry recognition Being named a Leader in the 2025 Everest Group RTSM PEAK Matrix reinforces credibility with prospective sponsors and CROs, providing a selling point for premium service levels, risk mitigation, and faster deployment timelines.

Technology backbone A tech stack built on cloud platforms and modern IT infrastructure (Azure, Google Cloud, Windows Server, HTTP/3, VMware) supports scalable, secure RTSM solutions, suggesting opportunities to propose integrated data analytics, cloud modernization, and interoperability enhancements with existing sponsor systems.